Session » (2177–2194) Sjögren’s Syndrome – Basic & Clinical Science Poster II

Date: Tuesday, November 14, 2023

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2023

9:00AM-11:00AM: Abstract Number: 2185

35 Years Follow-up of Primary Sjögren’s Disease: A Single Center Study

9:00AM-11:00AM: Abstract Number: 2193

Anti-citrullinated Protein Antibodies in Sjögren’s Syndrome Define a Subset of Patients with Lower B Cell Activation Markers and Higher Risk of Lung Involvement

9:00AM-11:00AM: Abstract Number: 2187

Association Between Illness Perception, Anxiety and Depression State, Disease Activity and Glucocorticoid Therapy in Patients with Sjӧgren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2194

Association of Self-perceived Oral Health Status with ESSPRI Reported by Sjögren’s Syndrome Patients

9:00AM-11:00AM: Abstract Number: 2177

Characterization of Crevicular Fluid Microbiota in Primary Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2184

Development of Salivary Gland Organoids to Study Sjögren Syndrome

9:00AM-11:00AM: Abstract Number: 2179

Disease Burden of Patients with Primary Sjögren’s Disease: Results from a Multinational Real-World Survey

9:00AM-11:00AM: Abstract Number: 2191

Efficacy of anti-CD38 Treatment with Daratumumab in Two Cases of Refractory and Severe Sjogren Disease

9:00AM-11:00AM: Abstract Number: 2183

Evolution of Lymphoma Predictors in Primary Sjogren’s Syndrome by Data Driven Analysis in Harmonized Patients

9:00AM-11:00AM: Abstract Number: 2178

Increased Risk of Dementia in Patients with Primary Sjogren’s Syndrome: A Nationwide Population-based Cohort Study

9:00AM-11:00AM: Abstract Number: 2188

Lung Cysts in Primary SS: New Findings on an Allegedly Innocuous Iiagnosis

9:00AM-11:00AM: Abstract Number: 2189

Lymphopenia Fluctuation Patterns Determine the Trajectory of the Disease in Sjogren’s Patients with Hematological Involvement

9:00AM-11:00AM: Abstract Number: 2182

Mitochondrial Alterations in Primary Sjögren´s Syndrome

9:00AM-11:00AM: Abstract Number: 2186

Neurological Complications in Sjögren’s: Occurrence & Impact on Patient Quality of Life

9:00AM-11:00AM: Abstract Number: 2192

New Inducible Mouse Model of Sjögren’s Syndrome Represents a Valuable Tool to Assess the Impact of Gene Knockout on the Disease’s Physiopathology

9:00AM-11:00AM: Abstract Number: 2190

Saliclick: A Novel Technology for Minimal Invasive Salivary Gland Biopsy in Suspected Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2180

Salivary and Plasma Mitochondrial Double-strand RNAs as a Diagnostic Biomarker for Sjӧgren Syndrome

9:00AM-11:00AM: Abstract Number: 2181

Secretagogue Effect of PDE4 Inhibitor Apremilast on Human Salivary Gland Organoids Obtained from Primary Sjögren’s Syndrome Patients

« View all sessions from this meeting